GIORDANO, Roberta

GIORDANO, Roberta  

SCIENZE CLINICHE E BIOLOGICHE  

Mostra records
Risultati 1 - 20 di 184 (tempo di esecuzione: 0.053 secondi).
Titolo Data di pubblicazione Autore(i) File
A CASE OF PRIMARY RETROPERITONEAL TERATOMA PRESENTING AS AN ADRENAL INCIDENTALOMA 2011 R. Giordano; G. Giraudo; D. Forno; M. Bosco; L. Delsedime; M. Morino; E. Arvat
A New Clinical Model to Estimate the Pre-Test Probability of Cushing's Syndrome: The Cushing Score 2021 Parasiliti-Caprino, Mirko; Bioletto, Fabio; Frigerio, Tommaso; D'Angelo, Valentina; Ceccato, Filippo; Ferraù, Francesco; Ferrigno, Rosario; Minnetti, Marianna; Scaroni, Carla; Cannavò, Salvatore; Pivonello, Rosario; Isidori, Andrea; Broglio, Fabio; Giordano, Roberta; Spinello, Maurizio; Grottoli, Silvia; Arvat, Emanuela
A retrospective study on the association between urine metanephrines and cardiometabolic risk in patients with nonfunctioning adrenal incidentaloma 2022 Parasiliti-Caprino, Mirko; Lopez, Chiara; Bollati, Martina; Bioletto, Fabio; Sola, Chiara; Di Carlo, Maria Chiara; Ponzetto, Federico; Gesmundo, Iacopo; Settanni, Fabio; Ghigo, Ezio; Mengozzi, Giulio; Maccario, Mauro; Giordano, Roberta
A Study of the serotoninergic tone in Healthy subjects and diabetic patients treated by a clinical-paedagogic approach (Group Care) or traditional care. 2007 Trento M; Tibaldi P; Balbo M; Kucich C; Basile M; Tomelini M; Passera P; Giordano R; Arvat E; Cavallo F; Porta M
ACTH-RELEASING EFFECTS OF HEXARELIN, A PEPTIDYL GH SECRETAGOGUE, IN NORMAL SUBJECTS PRETREATED WITH METYRAPONE OR RU486, A GLUCOCORTICOID RECEPTOR ANTAGONIST, AND IN PATIENTS WITH ADDISON'S DISEASE 1999 J. Ramunni; R. Giordano; L. Gianotti; A. Bertagna; A. Barberis; M. Boscaro; F. Camanni
ACUTE ADMINISTRATION OF ALPRAZOLAM, A BENZODIAZEPINE ACTIVATING GABA RECEPTORS, INHIBITS CORTISOL SECRETION IN PATIENTS WITH SUBCLINICAL BUT NOT OVERT CUSHING'S SYNDROME 2013 R. Giordano; R. Berardelli; I. Karamouzis; V. D’Angelo; A. Picu; C. Zichi.; B. Fussotto; M. Manzo; G. Mengozzi; E. Ghigo; E. Arvat
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study 2023 Massimo Terzolo; Martin Fassnacht; Paola Perotti; Rossella Libé; Darko Kastelan; André Lacroix; Wiebke Arlt; Harm Reinout Haak; Paola Loli; Bénédicte Decoudier; Helene Lasolle; Marcus Quinkler; Magalie Haissaguerre; Olivier Chabre; Philippe Caron; Antonio Stigliano; Roberta Giordano; Maria Chiara Zatelli; Irina Bancos; Maria Candida Barisson Villares Fragoso; Letizia Canu; Michaela Luconi; Soraya Puglisi; Vittoria Basile; Giuseppe Reimondo; Matthias Kroiss; Felix Megerle; Stefanie Hahner; Otilia Kimpel; Tina Dusek; Svenja Nölting; Isabelle Bourdeau; Vasileios Chortis; Madeleine Hester Ettaieb; Deborah Cosentini; Salvatore Grisanti; Eric Baudin; Paola Berchialla; Francesca Bovis; Maria Pia Sormani; Paolo Bruzzi; Felix Beuschlein; Jerome Bertherat; Alfredo Berruti.
ADRENAL SENSITIVITY TO ACTH1-24 AS FUNCTION OF AGE, BODY WEIGHT AND PITUITARY FUNCTION 2002 R. Giordano; R. Rossetto; C. Baffoni; F. Lanfranco; G. Aimaretti; L. Gianotti; S. Grottoli; M. Maccario; E. Ghigo; E. Arvat
ADRENAL SENSITIVITY TO ACTH1-24 AS FUNCTION OF AGE, BODY WEIGHT AND PITUITARY FUNCTION 2002 R. Giordano; R. Rossetto; C. Baffoni; F. Lanfranco; G. Aimaretti; L. Gianotti; S. Grottoli; M. Maccario; E. Ghigo; E. Arvat
Adrenal sensitivity to adrenocorticotropin 1-24 is reduced in patients with autoimmune polyglandular syndrome 2004 R. GIORDANO; M. PELLEGRINO; S. OLEANDRI; M. BALDI; M. BALBO; S. LAURETI; A. FALORNI; E. GHIGO; E. ARVAT
Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenoma. 1998 E. ARVAT; GIORDANO R.; RAMUNNI J.; ARNALDI G.; COLAO A.; DEGHENGHI R.; LOMBARDI G.; MANTERO F.; CAMANNI F.; GHIGO E.
ADULT PATIENTS WITH DOWN’S SYNDROME SHOW ENHANCED BASAL TSH LEVELS BUT NORMAL TSH RESPONSE TO TRH 2004 R. Giordano; J. Bellone; C. Origlia; M. Pellegrino; C. Baffoni; R. Rossetto; M. Maccario; A. Corrias; G. Aimaretti
Ageing, growth hormone and physical performance. 2003 LANFRANCO F; GIANOTTI L; GIORDANO R; PELLEGRINO M; MACCARIO M; ARVAT E
Alprazolam (a benzodiazepine activating GABA receptor) reduces the neuroendocrine responses to insulin-induced hypoglycaemia in humans. 2003 GIORDANO R; GROTTOLI S; BROSSA P.C; PELLEGRINO M; DESTEFANIS S; LANFRANCO F; GIANOTTI L; GHIGO E; ARVAT E
Alprazolam, a benzodiazepine, blunts but does not abolish the ACTH and cortisol response to hexarelin, a GHRP, in obese patients. 2000 S. GROTTOLI; E. ARVAT; C. GAUNA; B. MACCAGNO; J. RAMUNNI; R. GIORDANO; M. MACCARIO; R. DEGHENGHI; E. GHIGO
Alprazolam, a benzodiazepine, does not modify the ACTH and cortisol response to hCRH and AVP, but blunts the cortisol response to ACTH in humans. 2002 GROTTOLI S ;MACCAGNO B ;RAMUNNI J ;DI VITO L ;GIORDANO R ;GIANOTTI L ;DESTEFANIS S ;CAMANNI F ;GHIGO E ;ARVAT E
AUTOANTIBODY RESPONSE AGAINST NALP5/MATER IN PRIMARY OVARIAN INSUFFICIENCY AND IN AUTOIMMUNE ADDISON’S DISEASE 2015 Brozzetti, A; Alimohammadi, M; Morelli, S; Minarelli, V; Halkgren, Å; Giordano, R; Bellis, A D; Perniola, R; Kämpe, O; Falorni, A
AUTOANTIBODY RESPONSES IN AUTOIMMUNE OVARIAN INSUFFICIENCY AND IN ADDISON DISEASE ARE IGG1-DOMINATED AND SUGGEST A PREDOMINANT, BUT NOT EXCLUSIVE, TH1 TYPE OF RESPONSE 2010 A. Brozzetti; S. Marzotti; D. La Torre; M.L. Bacosi; S. Morelli; V. Bini; B. Ambrosi; R. Giordano; R. Perniola; A. De Bellis; C. Betterle; A. Falorni
AUTOIMMUNE POLYENDOCRINOPATHY-CANDIDIASIS-ECTODERMAL-DYSTROPHY (APECED) IN SICILY: CONFIRMATION THAT R203X IS THE PECULIAR AIRE GENE MUTATION 2012 C. Giordano; R. Modica; M. L. Allotta; V. Guarnotta; S. Cervato; S. Masiero; R. Giordano; S. Garelli; C. Betterle
BASAL AND STIMULATED GH SECRETION IN CUSHING’S SYNDROME: EFFECTS OF GHRELIN AND GHRH+ARGININE 2009 A. Picu; E. Marinazzo; F. Prodam; F. Broglio; S. Belcastro; G. Amaretti; R. Giordano; E. Ghigo; E. Arvat